Shuguftha Naz
Affiliations: | 2017 | Pittsburg State University, Pittsburg, KS, United States |
Google:
"Shuguftha Naz"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Naz S, Banerjee T, Totsingan F, et al. (2021) Therapeutic Efficacy of Lactonic Sophorolipids: Nanoceria-Assisted Combination Therapy of NSCLC using HDAC and Hsp90 Inhibitors. Nanotheranostics. 5: 391-404 |
| Ur Rehman F, Mazhar K, Malik A, et al. (2021) Surface modified multifaceted nanocarriers for oral non-conventional cancer therapy; synthesis and evaluation. Materials Science & Engineering. C, Materials For Biological Applications. 123: 111940 |
| Rehman FU, Al-Waeel M, Naz SS, et al. (2020) Anticancer therapeutics: a brief account on wide refinements. American Journal of Cancer Research. 10: 3599-3621 |
| Rehman FU, Al-Waeel M, Naz SS, et al. (2020) Anticancer therapeutics: a brief account on wide refinements. American Journal of Cancer Research. 10: 3599-3621 |
| Zafar N, Madni A, Khalid A, et al. (2020) Pharmaceutical and Biomedical Applications of Green Synthesized Metal and Metal Oxide Nanoparticles. Current Pharmaceutical Design |
| Heckert B, Banerjee T, Sulthana S, et al. (2017) Design and Synthesis of New Sulfur-Containing Hyperbranched Polymer and Theranostic Nanomaterials for Bimodal Imaging and Treatment of Cancer. Acs Macro Letters. 6: 235-240 |
| Naz S, Beach J, Heckert B, et al. (2017) Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment. Nanomedicine (London, England) |
| Sulthana S, Banerjee T, Kallu J, et al. (2017) Combination Therapy of NSCLC Using Hsp90 Inhibitor and Doxorubicin Carrying Functional Nanoceria. Molecular Pharmaceutics |